XML 94 R32.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Equity Incentive Compensation Plans and Other Long-term Incentive Programs (Tables)
 12 Months Ended
Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Non-Cash Stock-Based Compensation Cost Related to Equity Awards
The following table presents the long-term equity and cash incentive compensation related to awards for the periods indicated:

 
Year Ended December 31,
 
2019
 
2018
 
2017
 
(in thousands)
Nonvested common stock (1)
$
6,601

 
$
6,036

 
$
5,852

Nonvested common stock units (1)
1,177

 
1,138

 
690

Nonvested performance-based shares
—

 
—

 
558

Nonvested performance cash units (2)(3)
844

 
52

 
1,189

Total
$
8,622

 
$
7,226

 
$
8,289


(1)
Unrecognized compensation cost as of December 31, 2019 was $5.9 million related to grants of nonvested shares of common stock and common stock units that are expected to be recognized over a weighted-average period of 1.6 years.
(2)
The nonvested performance-based cash units are accounted for as liability awards with $1.4 million in accounts payable and accrued liabilities as of December 31, 2017, and $1.2 million, $0.3 million and $3.0 million in other noncurrent liabilities as of December 31, 2019, 2018 and 2017, respectively, in the Consolidated Balance Sheets.
(3)
Liability awards are fair valued at each reporting date. The expense for the period will increase or decrease based on updated fair values of these awards at each reporting date.
Schedule of Share-Based Option Activity
A summary of share-based option activity under all the Company's plans as of December 31, 2019, and changes during the year then ended, is presented below:

Option Awards
 
Shares
 
Weighted Average
Exercise Price
Outstanding at January 1, 2019
 
126,843

 
$
27.25

Granted (1)
 
—

 
—

Exercised
 
—

 
—

Forfeited or expired
 
(126,843
)
 
27.25

Outstanding at December 31, 2019 (2)
 
—

 
—



(1)
The Company has not granted any share-based option awards since 2012.
(2)
At December 31, 2019, there are no outstanding share-based option awards.
Schedule of Deferred Compensation Liability
The table below summarizes the activity in the plan as of December 31, 2019 and 2018, and the Company's ending deferred compensation liability as of December 31, 2019 and 2018:

 
As of December 31,
 
2019
 
2018
 
(in thousands)
Beginning deferred compensation liability balance
$
1,392

 
$
1,749

Employee contributions
276

 
370

Company matching contributions
150

 
198

Distributions
(193
)
 
(806
)
Participant earnings (losses)
408

 
(119
)
Ending deferred compensation liability balance
$
2,033

 
$
1,392

 
 
 
 
Amount to be paid within one year
$
844

 
$
94

Remaining balance to be paid beyond one year
$
1,189

 
$
1,298
Schedule of Deferred Compensation Investment Assets
The following table represents the Company's activity in the investment assets held in the rabbi trust as of December 31, 2019 and 2018:

 
As of December 31,
 
2019
 
2018
 
(in thousands)
Beginning investment balance
$
1,392

 
$
1,749

Investment purchases
426

 
568

Distributions
(193
)
 
(806
)
Earnings (losses)
408

 
(119
)
Ending investment balance
$
2,033

 
$
1,392
Director  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Nonvested Equity Shares of Common Stock A summary of the Company's nonvested common stock units for the years ended December 31, 2019, 2018 and 2017 is presented in the table below:

 
 
Year Ended December 31,
 
 
2019
 
2018
 
2017
Nonvested Common Stock Unit Awards
 
Units
 
Weighted
Average
Grant Date
Fair Value 
 
Units
 
Weighted
Average
Grant Date
Fair Value 
 
Units
 
Weighted
Average
Grant Date
Fair Value 
Outstanding at January 1,
 
311,237

 
$
7.26

 
272,559

 
$
6.37

 
147,167

 
$
10.09

Granted
 
643,084

 
1.88

 
226,244

 
5.83

 
193,878

 
3.56

Vested (1)
 
(158,218
)
 
5.44

 
(187,566
)
 
4.24

 
(68,486
)
 
6.42

Forfeited or expired
 
—

 
—

 
—

 
—

 
—

 
—

Outstanding at December 31,
 
796,103

 
3.27

 
311,237

 
7.26

 
272,559

 
6.37



(1)
The fair value of common stock unit awards vested was $0.3 million, $1.1 million and $0.2 million for the years ended December 31, 2019, 2018 and 2017, respectively.
Nonvested Common Stock  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Nonvested Equity Shares of Common Stock A summary of the Company's nonvested common stock awards for the years ended December 31, 2019, 2018 and 2017 is presented below:

 
 
Year Ended December 31,
 
 
2019
 
2018
 
2017
Nonvested Common Stock Awards
 
Shares
 
Weighted
Average
Grant Date
Fair Value 
 
Shares
 
Weighted
Average
Grant Date
Fair Value 
 
Shares
 
Weighted
Average
Grant Date
Fair Value 
Outstanding at January 1,
 
2,912,166

 
$
5.27

 
1,394,868

 
$
7.00

 
1,169,099

 
$
9.33

Granted
 
1,847,700

 
2.64

 
1,185,809

 
5.47

 
791,129

 
5.99

Modified (1)
 
—

 
—

 
1,146,305

 
4.84

 
—

 
—

Vested (2)
 
(1,696,963
)
 
4.99

 
(694,505
)
 
8.24

 
(513,376
)
 
10.74

Forfeited or expired
 
(94,406
)
 
4.91

 
(120,311
)
 
5.93

 
(51,984
)
 
7.91

Outstanding at December 31,
 
2,968,497

 
3.81

 
2,912,166

 
5.27

 
1,394,868

 
7.00



(1)
Due to the closing of the Merger, the 2016 and 2017 Performance Cash Programs were converted from nonvested performance-based cash units to nonvested common stock awards, resulting in an increase of nonvested common stock awards for the year ended December 31, 2018.
(2)
The fair value of common stock awards vested was $4.1 million, $3.7 million and $2.9 million for the years ended December 31, 2019, 2018 and 2017, respectively.
Nonvested Performance Cash Units  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Nonvested Performance-Based Equity Shares of Common Stock A summary of the Company's nonvested performance-based cash units for the years ended December 31, 2019, 2018 and 2017 is presented below:

 
 
Year Ended December 31,
 
 
2019
 
2018
 
2017
Nonvested Performance-Based
Cash Unit Awards
 
Units
 
Weighted
Average
Fair Value 
 
Units
 
Weighted
Average
Fair Value 
 
Units
 
Weighted
Average
Fair Value 
Outstanding at January 1,
 
909,585

 
 
 
1,548,083

 
 
 
942,326

 
 
Granted
 
2,026,521

 
 
 
935,293

 
 
 
669,043

 
 
Performance goal adjustment (1)
 
—

 
 
 
11,289

 
 
 
—

 
 
Modified (2)
 
—

 
 
 
(1,211,478
)
 
 
 
—

 
 
Vested (3)
 
—

 
 
 
(286,652
)
 
 
 
—

 
 
Forfeited or expired
 
(360,044
)
 
 
 
(86,950
)
 
 
 
(63,286
)
 
 
Outstanding at December 31,
 
2,576,062

 
$
1.38

 
909,585

 
$
1.23

 
1,548,083

 
$
5.10



(1)
The 2015 Program vested at 104.1% of the target level and resulted in additional units vesting in March 2018. These units are included in the vested line item for the year ended December 31, 2018.
(2)
Due to the closing of the Merger, the 2016 and 2017 Performance Cash Programs were converted from nonvested performance-based cash units to nonvested common stock awards, resulting in a decrease in nonvested performance-based cash units for the year ended December 31, 2018. The 2016 Program converted based on performance through March 19, 2018, which resulted in 89% of the units converting to nonvested common stock awards or a reduction of 65,173 units converting to nonvested common stock awards.
(3)
The fair value of performance-based cash unit awards vested was $1.5 million for the year ended December 31, 2018. No awards vested in 2019 or 2017.
Nonvested Performance-Based Equity  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Nonvested Equity Shares of Common Stock A summary of the Company's vested performance-based shares of common stock for the years ended December 31, 2019, 2018 and 2017 is presented below:
 
 
Year Ended December 31,
 
 
2019
 
2018
 
2017
Nonvested Performance-Based
Common Stock Awards
 
Shares
 
Weighted
Average
Grant Date
Fair Value 
 
Shares
 
Weighted
Average
Grant Date
Fair Value 
 
Shares
 
Weighted
Average
Grant Date
Fair Value 
Outstanding at January 1,
 
—

 
$
—

 
—

 
$
—

 
156,615

 
$
19.54

Granted (1)
 
—

 
—

 
—

 
—

 
—

 
—

Performance goal adjustment (2)
 
—

 
—

 
—

 
—

 
10,450

 
24.45

Vested (3)
 
—

 
—

 
—

 
—

 
(166,023
)
 
24.45

Forfeited or expired
 
—

 
—

 
—

 
—

 
(1,042
)
 
24.62

Outstanding at December 31,
 
—

 
—

 
—

 
—

 
—

 
—



(1)
The Company has not granted any performance-based common stock awards since 2014.
(2)
The 2014 Program vested at 106.7% of target level and resulted in additional shares vesting in May 2017. These shares are included in the vested line item for the year ended December 31, 2017.
(3)
The fair value of performance-based common stock awards vested was $0.6 million for the year ended December 31, 2017. No awards vested in 2019 or 2018.